{
  "actions": [
    {
      "acted_at": "2004-10-08",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2004-10-08",
      "action_code": "B00100",
      "references": [
        {
          "reference": "CR S10847-10848",
          "type": null
        }
      ],
      "text": "Sponsor introductory remarks on measure.",
      "type": "action"
    },
    {
      "acted_at": "2004-10-08",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [
        {
          "reference": "CR S10848",
          "type": "text of measure as introduced"
        }
      ],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s2944-108",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "108",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2004-10-08",
  "number": "2944",
  "official_title": "A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "W000779",
    "district": null,
    "name": "Wyden, Ron",
    "state": "OR",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2004-10-08",
  "subjects": [
    "AIDS (Disease)",
    "Clinical trials",
    "Commerce",
    "Drug approvals",
    "Drug industry",
    "Drugs",
    "Emergency Management",
    "Emergency medicine",
    "Epidemics",
    "Foreign trade and international finance",
    "Generic drugs",
    "Government Operations and Politics",
    "Health",
    "Human immunodeficiency viruses",
    "International Affairs",
    "Malaria",
    "Office of the U.S. Trade Representative",
    "Trade agreements",
    "Trade negotiations",
    "Tuberculosis"
  ],
  "subjects_top_term": "Foreign trade and international finance",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2004-10-08",
    "date": "2004-12-03T21:16:11Z",
    "text": "Prohibits funds appropriated or otherwise obligated to the U.S. Trade Representative from being expended to negotiate data exclusivity provisions with any country with respect to public health pharmaceutical products or to require actions of another country which interfere with a country's access to such products."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.",
      "type": "official"
    }
  ],
  "updated_at": "2023-01-14T22:48:35Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/108/s/BILLSTATUS-108s2944.xml"
}